BioCardia (BCDA) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 8, 2026

Net buying: insiders sold $0 and bought $11K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$11K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about BCDA filings

Are insiders buying or selling Biocardia Inc (BCDA) stock?

Net buying: insiders sold $0 and bought $11K of BCDA stock on the open market in the 90 days to Nov 8, 2026, according to SEC Form 4 filings. The largest was Altman, Peter (President and CEO), who bought $11K. The latest filing was on Oct 20, 2026.

Which members of Congress have traded BCDA recently?

None. No member of Congress disclosed a BCDA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BCDA smart-money data?

This summary uses filings available on Nov 8, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on BCDA

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean long3 buys · $3.5K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about BCDA filings

Are insiders buying or selling Biocardia Inc (BCDA) stock?

Which members of Congress have traded BCDA recently?

None. No member of Congress disclosed a BCDA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BCDA smart-money data?

Insiders

What insiders are doing

12 trades · 6 mo

Bought$135K

Buys (3)

AP
Altman Peter
President and CEO · Oct 20
$475
bought
AP
Altman Peter
President and CEO · Sep 30
$1K
bought
AP
Altman Peter
President and CEO · Sep 24
$2K
bought

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 10, 2026

Earnings came in 31.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 10, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.13+31.58% beat

-$0.19 expected

Revenue (FY)

$0.00

Year ended Dec 31, 2025 · SEC filing

Next report

Estimated report: Nov 11, 2026, in 3 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 10, 2026	-$0.13est. -$0.19	+31.58%beat	Not on file	Not on file
Mar 31, 2026Reported May 15, 2026	-$0.21est. -$0.17	-23.53%miss	Not on file	Not on file
Dec 31, 2025Reported Mar 24, 2026	-$0.06est. -$0.20	+70.00%beat	$0.00 · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	-$0.24est. -$0.25	+4.00%beat	$0.00SEC filing	No year-ago quarter
Jun 30, 2025Reported Aug 11, 2025	-$0.40est. -$0.50	+20.00%beat	$0.00SEC filing	-100.0%from $3.0K
Mar 31, 2025Reported May 14, 2025	-$0.59est. -$0.39	-51.28%miss	$0.00SEC filing	-100.0%from $55.0K
Dec 31, 2024Reported Mar 26, 2025	-$0.25est. -$0.87	+71.26%beat	$58.0K · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 13, 2024	-$0.61est. -$1.19	+48.74%beat	$0.00SEC filing	-100.0%from $357.0K

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $0.94
High: $0.98
Low: $0.90
Prev close: $0.90
52-wk high: $1.50
52-wk low: $0.75
Mkt cap: $12.9M
ROE: -1803.0%
Beta: 0.65
P/S: 2520.6x
P/B: 4.9x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $13M

Valuation

P/S2520.59
P/B4.93

Quality

Operating margin0.0%
ROE-1803.0%
ROA-135.0%

Growth

Beta0.65

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

15 / 100

RSI 14

49balanced

20D volatility

78%annualized

52-week range

$0.92

$0.75$1.50

20D support

$0.86recent floor

20D resistance

$1.09recent ceiling

Returns

5D +0.0%20D -13.1%60D -4.7%

Price vs moving averages

SMA20 -3.7%SMA50 -11.8%SMA200 -14.0%

Volume pace

0.33xvs prior 20D

Smart money at a glance

Filings to Nov 8, 2026

Net buying: insiders sold $0 and bought $11K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$11K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about BCDA filings

Are insiders buying or selling Biocardia Inc (BCDA) stock?

Which members of Congress have traded BCDA recently?

None. No member of Congress disclosed a BCDA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BCDA smart-money data?

Smart money on BCDA

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean long3 buys · $3.5K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about BCDA filings

Are insiders buying or selling Biocardia Inc (BCDA) stock?

Which members of Congress have traded BCDA recently?

None. No member of Congress disclosed a BCDA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BCDA smart-money data?

Insiders

What insiders are doing

12 trades · 6 mo

Bought$135K

Buys (3)

AP
Altman Peter
President and CEO · Oct 20
$475
bought
AP
Altman Peter
President and CEO · Sep 30
$1K
bought
AP
Altman Peter
President and CEO · Sep 24
$2K
bought

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 10, 2026

Earnings came in 31.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 10, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.13+31.58% beat

-$0.19 expected

Revenue (FY)

$0.00

Year ended Dec 31, 2025 · SEC filing

Next report

Estimated report: Nov 11, 2026, in 3 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 10, 2026	-$0.13est. -$0.19	+31.58%beat	Not on file	Not on file
Mar 31, 2026Reported May 15, 2026	-$0.21est. -$0.17	-23.53%miss	Not on file	Not on file
Dec 31, 2025Reported Mar 24, 2026	-$0.06est. -$0.20	+70.00%beat	$0.00 · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	-$0.24est. -$0.25	+4.00%beat	$0.00SEC filing	No year-ago quarter
Jun 30, 2025Reported Aug 11, 2025	-$0.40est. -$0.50	+20.00%beat	$0.00SEC filing	-100.0%from $3.0K
Mar 31, 2025Reported May 14, 2025	-$0.59est. -$0.39	-51.28%miss	$0.00SEC filing	-100.0%from $55.0K
Dec 31, 2024Reported Mar 26, 2025	-$0.25est. -$0.87	+71.26%beat	$58.0K · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 13, 2024	-$0.61est. -$1.19	+48.74%beat	$0.00SEC filing	-100.0%from $357.0K

Open: $0.94
High: $0.98
Low: $0.90
Prev close: $0.90
52-wk high: $1.50
52-wk low: $0.75
Mkt cap: $12.9M
ROE: -1803.0%
Beta: 0.65
P/S: 2520.6x
P/B: 4.9x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $13M

Valuation

P/S2520.59
P/B4.93

Quality

Operating margin0.0%
ROE-1803.0%
ROA-135.0%

Growth

Beta0.65

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

15 / 100

RSI 14

49balanced

20D volatility

78%annualized

52-week range

$0.92

$0.75$1.50

20D support

$0.86recent floor

20D resistance

$1.09recent ceiling

Returns

5D +0.0%20D -13.1%60D -4.7%

Price vs moving averages

SMA20 -3.7%SMA50 -11.8%SMA200 -14.0%

Volume pace

0.33xvs prior 20D

Biocardia Inc

Smart money at a glance

What do analysts expect?

Questions about BCDA filings

Smart money on BCDA

Questions about BCDA filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 31.6% above what analysts expected.

Estimated report: Nov 11, 2026, in 3 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Biocardia Inc

Smart money at a glance

What do analysts expect?

Questions about BCDA filings

Smart money on BCDA

Questions about BCDA filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 31.6% above what analysts expected.

Estimated report: Nov 11, 2026, in 3 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Biocardia Inc

Overview

Questions about BCDA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Biocardia Inc

Overview

Questions about BCDA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.